Combined approach could boost breast cancer immunotherapy, study suggests
2021-01-02
(Press-News.org) Activating an immune signaling pathway best known for fighting viral and bacterial infections can boost the ability of genetically engineered T cells to eradicate breast cancer in mice, according to a new study by researchers at the University of North Carolina. The study, to be published December 31 in the Journal of Experimental Medicine (JEM), suggests that CAR T cells, which are already used to treat certain blood cancers in humans, may also be successful against solid tumors if combined with other immunotherapeutic approaches.
Chimeric antigen receptor (CAR) T cells are a type of white blood cell that have been genetically engineered to recognize and attack cancer cells expressing specific proteins on their surface. They have been successfully used to treat patients with B cell lymphomas and are currently undergoing clinical trials for the treatment of many other types of blood cancer. "However, the clinical activity of CAR T cells in patients or animal models with solid tumors has been modest," says Jonathan S. Serody, the Elizabeth Thomas Professor of Medicine, Microbiology, and Immunology and Director of the Cellular Therapy Program at the University of North Carolina School of Medicine.
CAR T cells may be less effective against solid tumors because they have to migrate into the tumors and then survive long enough to kill all of the tumor cells. Moreover, the cells and molecules surrounding tumors are often immunosuppressive, activating an immune checkpoint that causes the CAR T cells to lose their activity.
In the new study, Serody and colleagues tested several strategies to boost the effectiveness of CAR T cells in a mouse model of breast cancer. One effective strategy was to simultaneously treat the mice with drugs, such as cGAMP, that activate the STING pathway, an immune cell signaling pathway that normally induces inflammation in response to invading viruses or bacteria. Activating the STING pathway created a proinflammatory environment within the mouse tumors, improving the CAR T cells' ability to accumulate and attack the tumor cells. The accumulation was particularly great when the mice were infused with CAR T cells that produce the immune signaling molecule IL-17A, compared with CAR T cells generated using standard techniques.
Serody and colleagues determined that the CAR T cells' attack could be sustained for longer periods if the mice were also treated with therapeutic antibodies that deplete immunosuppressive cells from the tumor environment and prevent the immune checkpoint from deactivating the CAR T cells. The researchers found that combining all of these approaches led to the complete eradication of breast tumors.
"cGAMP is in clinical trials for the treatment of patients with cancer, there are multiple ongoing clinical trials using approaches to inhibit immunosuppressive cells for patients with malignant disease, and there are clinical trials currently evaluating the combination of CAR T cells with immune checkpoint blockade," Serody says. "Together therefore, our data suggest a viable strategy for boosting CAR T activity in solid tumors."
INFORMATION:
Xu et al. 2020. J. Exp. Med. https://rupress.org/jem/article-lookup/doi/10.1084/jem.20200844?PR
About the Journal of Experimental Medicine
The Journal of Experimental Medicine (JEM) features peer-reviewed research on immunology, cancer biology, stem cell biology, microbial pathogenesis, vascular biology, and neurobiology. All editorial decisions are made by research-active scientists in conjunction with in-house scientific editors. JEM makes all of its content free online no later than six months after publication. Established in 1896, JEM is published by Rockefeller University Press. For more information, visit jem.org.
Visit our Newsroom, and sign up for a weekly preview of articles to be published. Embargoed media alerts are for journalists only.
Follow JEM on Twitter at @JExpMed and @RockUPress.
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2021-01-02
The Asian tiger mosquito does not pose a major risk for Zika virus epidemics, according to a study published December 31 in the open-access journal PLOS Pathogens by Albin Fontaine of the Institut de Recherche Biomédicale des Armées, and colleagues.
Zika virus has triggered large outbreaks in human populations, in some cases causing congenital deformities, fetal loss, or neurological problems in adults. While the yellow fever mosquito Aedes aegypti is considered the primary vector of Zika ...
2021-01-02
A novel computational drug screening strategy combined with lab experiments suggest that pralatrexate, a chemotherapy medication originally developed to treat lymphoma, could potentially be repurposed to treat Covid-19. Haiping Zhang of the Shenzhen Institutes of Advanced Technology in Shenzhen, China, and colleagues present these findings in the open-access journal PLOS Computational Biology.
With the Covid-19 pandemic causing illness and death worldwide, better treatments are urgently needed. One shortcut could be to repurpose existing drugs that were originally developed to ...
2021-01-02
Multiple bouts of blood feeding by mosquitoes shorten the incubation period for malaria parasites and increase malaria transmission potential, according to a study published December 31 in the open-access journal PLOS Pathogens by Lauren Childs of Virginia Tech, Flaminia Catteruccia of the Harvard T.H. Chan School of Public Health, and colleagues. Given that mosquitoes feed on blood multiple times in natural settings, the results suggest that malaria elimination may be substantially more challenging than suggested by previous experiments, which typically involve a single blood meal.
Malaria ...
2021-01-02
The discovery of new drugs is vital to achieving the eradication of neglected tropical diseases (NTDs) in Africa and around the world. Now, researchers reporting in PLOS Neglected Tropical Diseases have identified traditional Ghanaian medicines which work in the lab against schistosomiasis, onchocerciasis and lymphatic filariasis, three diseases endemic to Ghana.
The major intervention for NTDs in Ghana is currently mass drug administration of a few repeatedly recycled drugs, which can lead to reduced efficacy and the emergence of drug resistance. Chronic infections of schistosomiasis, onchocerciasis and lymphatic filariasis ...
2021-01-02
In the ongoing arms race between humans and the parasite that causes malaria, Taane Clark and colleagues at the London School of Hygiene and Tropical Medicine (LSHTM) report that new mutations that enhance resistance to a drug used to prevent malaria in pregnant women and children are already common in countries fighting the disease. The new results are published December 31 in PLOS Genetics.
Malaria causes about 435,000 deaths each year, primarily in young children in sub-Saharan Africa. Despite a long-term global response, efforts to control the disease are hampered by the rise of drug-resistant strains of the parasite species that cause malaria. Sulfadoxine-pyrimethamine (SP), ...
2021-01-02
UNIVERSITY PARK, Pa. -- A desalination membrane acts as a filter for salty water: push the water through the membrane, get clean water suitable for agriculture, energy production and even drinking. The process seems simple enough, but it contains complex intricacies that have baffled scientists for decades -- until now.
Researchers from Penn State, The University of Texas at Austin, Iowa State University, Dow Chemical Company and DuPont Water Solutions published a key finding in understanding how membranes actually filter minerals from water, online today (Dec. 31) in Science. The article will be featured on the print edition's cover, to be issued tomorrow (Jan. ...
2021-01-02
Predicting when and how collections of particles, robots, or animals become orderly remains a challenge across science and engineering.
In the 19th century, scientists and engineers developed the discipline of statistical mechanics, which predicts how groups of simple particles transition between order and disorder, as when a collection of randomly colliding atoms freezes to form a uniform crystal lattice.
More challenging to predict are the collective behaviors that can be achieved when the particles ...
2021-01-02
High in the clouds, atmospheric aerosols, including anthropogenic air pollutants, increase updraft speeds in storm clouds by making the surrounding air more humid, a new study finds. The results offer a new mechanism explaining the widely observed - but poorly understood - atmospheric phenomenon and provide a physical basis for predicting increasing thunderstorm intensity, particularly in the high-aerosol regions of the tropics. Observations worldwide have highlighted aerosols' impact on weather, including their ability to strengthen convection in deep convective clouds, like those ...
2021-01-02
A new analysis suggests that, by 2040, 19% of the world's population - accounting for 21% of the global Gross Domestic Product - will be impacted by subsidence, the sinking of the ground's surface, a phenomenon often caused by human activities such as groundwater removal, and by natural causes as well. The results, reported in a Policy Forum, represent "a key first step toward formulating effective land-subsidence policies that are lacking in most countries worldwide," the authors say. Gerardo Herrera Garcia et al. performed a large-scale ...
2021-01-02
When the COVID-19 pandemic reached Africa, the continent was already struggling to deal with another public health crisis - a growing cancer epidemic characterized by more than one million new cancer cases and nearly 700,000 deaths per year. In a Perspective, Beatrice Wiafe Addai and Wilfred Ngwa discuss the significant challenges COVID-19 imposed on cancer prevention and control in Africa and how the efforts to address these challenges highlight key opportunities where greater investment could improve cancer care globally. At the start of the pandemic, many African ...
LAST 30 PRESS RELEASES:
[Press-News.org] Combined approach could boost breast cancer immunotherapy, study suggests
